Stella Chemifa Corporation (TYO:4109)

Longboard Pharmaceuticals Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	14,665	16,643	16,225	15,097	15,895	15,568
Cash & Short-Term Investments	14,665	16,643	16,225	15,097	15,895	15,568
Cash Growth	1.59%	2.58%	7.47%	-5.02%	2.10%	14.55%
Receivables	7,419	7,107	6,785	7,096	8,625	8,465
Inventory	5,534	5,616	5,475	5,496	5,269	4,871
Other Current Assets	506	473	517	926	792	610
Total Current Assets	28,124	29,839	29,002	28,615	30,581	29,514
Property, Plant & Equipment	26,764	26,658	25,426	22,625	21,667	21,564
Long-Term Investments	4,059	3,583	3,446	3,513	3,643	991
Other Intangible Assets	42	42	149	261	375	516
Long-Term Deferred Tax Assets	-	603	593	457	330	347
Other Long-Term Assets	2	-	2	-	2	1
Total Assets	58,991	60,725	58,618	55,471	56,598	52,933
Accounts Payable	2,511	2,500	1,966	2,268	2,619	2,073
Accrued Expenses	202	438	431	423	434	423
Short-Term Debt	2,311	2,581	3,186	2,989	2,321	2,359
Current Portion of Long-Term Debt	1,008	949	978	932	1,494	2,004
Current Income Taxes Payable	1,264	2,506	1,277	1,706	2,272	1,876
Other Current Liabilities	860	810	1,052	576	664	739
Total Current Liabilities	8,156	9,784	8,890	8,894	9,804	9,474
Long-Term Debt	2,867	2,424	1,949	1,070	2,003	4,751
Other Long-Term Liabilities	2,533	2,517	2,280	1,362	1,078	964
Total Liabilities	14,581	15,733	14,118	12,310	13,872	16,177
Common Stock	4,829	4,829	4,829	4,829	4,829	4,829
Additional Paid-In Capital	8,770	8,760	8,797	8,793	8,793	7,311
Retained Earnings	31,548	31,734	31,655	30,904	29,450	24,719
Treasury Stock	-3,230	-3,271	-2,957	-2,991	-1,642	-795
Comprehensive Income & Other	2,267	2,700	1,936	1,388	788	206
Total Common Equity	44,184	44,752	44,260	42,923	42,218	36,270
Minority Interest	226	240	240	238	508	486
Shareholders' Equity	44,410	44,992	44,500	43,161	42,726	36,756
Total Liabilities & Equity	58,991	60,725	58,618	55,471	56,598	52,933
Total Debt	6,186	5,954	6,113	4,991	5,818	9,114
Net Cash (Debt)	8,479	10,689	10,112	10,106	10,077	6,454
Net Cash Growth	-13.21%	5.71%	0.06%	0.29%	56.14%	242.57%
Net Cash Per Share	710.67	890.60	840.98	824.31	794.53	503.16
Filing Date Shares Outstanding	11.8	11.8	12.03	12.01	12.51	12.81
Total Common Shares Outstanding	11.8	11.8	12.03	12.01	12.51	12.81
Working Capital	19,968	20,055	20,112	19,721	20,777	20,040
Book Value Per Share	3743.48	3791.70	3679.76	3572.62	3373.72	2830.60
Tangible Book Value	44,142	44,710	44,111	42,662	41,843	35,754
Tangible Book Value Per Share	3739.92	3788.14	3667.37	3550.90	3343.75	2790.33

Source: S&P Global Market Intelligence. Standard template. Financial Sources.